The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
KEYNOTE-355: Randomized, double-blind, phase III study of pembrolizumab (pembro) + chemotherapy (chemo) vs placebo (PBO) + chemo for previously untreated, locally recurrent, inoperable or metastatic triple-negative breast cancer (mTNBC).
 
Javier Cortés
Stock and Other Ownership Interests - MedSIR
Honoraria - Celgene; Eisai; Novartis; Pfizer; Roche
Consulting or Advisory Role - AstraZeneca; Biothera; Celgene; Cellestia Biotech; Roche
 
Zifang Guo
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Vassiliki Karantza
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Gursel Aktan
Employment - Merck; Merck (I)
Stock and Other Ownership Interests - Merck; Merck (I)
Travel, Accommodations, Expenses - Merck; Merck (I)
Other Relationship - Merck (I)